Company
Human Longevity
To make longer, healthier, and fully functional lives possible for all — powered by genomics, AI, precision medicine, and the next generation of longevity technologies.
- Status
- Operatingas of 2026-09-22
- Business model
- B2C
- Headquarters
- San Francisco, CA, United States
- Founded
- 2013
- Customers
- Members
- Legal name
- Human Longevity, Inc.
- humanlongevity.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Most people only see a doctor when something feels wrong. By then, the window for meaningful intervention has often closed. Human Longevity was built on a different premise: that biology gives us signals long before disease becomes visible — and that catching those signals early is the difference between prevention and treatment.
Funding snapshot
- Total raised
- $59MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series B, $39.8M2024
Funding rounds
- Series B
- $39.8M2024, Company stated
- Round, 2023
- $32M2023-03-13, SEC form D sold, 18 investors
- Round, 2021
- $6.9M2021-09-27, SEC form D sold, 11 investors
- Round, 2019
- $20.1M2019-06-14, SEC form D sold, 1 investor
Products
- Other
- 100+ Care
- Other
- Executive Health
- Other
- Genomics for All
Loading relationship preview